Vivosang Inc
Vivosang Inc is an investigational stage biotechnology company focused on developing pegylated human hemoglobin products to enhance oxygen delivery in medical applications, particularly in traumatic hemorrhagic injuries. Their lead product, VS-101, aims to provide targeted oxygen delivery to tissues in need, addressing significant medical needs in emergency and surgical settings.
Vivosang Inc
What We Do
VS-101
An investigational biopharmaceutical product designed to provide targeted oxygen delivery in capillaries and enhance perfusion of oxygen-deprived tissues. It is based on unmodified human hemoglobin tetramers extracted from outdated human red blood cells, conjugated with polyethylene glycol (PEG) to improve oxygen-carrying capacity and delivery.
Battlefield Resuscitation
Biologics
Drugs
Routes of Administration
Key People
William Schindler JD
President, CEO
Kim Vandegriff PhD
Chief Science Officer
Ashok Malavalli MS
Chief of Operations
News & Updates
2023 Military Health Systems Research Symposium
Presentation on 'Novel PEGylated HBOC Bridges Circulatory Function and Oxygen Delivery in Rat Exchange Transfusion.'